Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guangdong BPC raw material receiving records, Kaiser repacking irregularities cited in warning letters.

Executive Summary

GUANGDONG PHARMACEUTICAL RECEIVING RECORDS ARE "INNACCURATE" and "incomplete" for the factory in Guangzhou City, China, FDA told the bulk pharmaceutical company in a March 10 FDA warning letter. The agency documented recordkeeping insufficiencies for raw material receiving records and finished product distribution records during an inspection of the Chinese BPC facility from Sept. 5 through Sept. 7.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS025951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel